Member Info for coaster

Very difficult to understand this other than manipulation. Seems to be extreme in the case of SBRY's.

No need for concern. GSK still hold a prominent position in the treatment of HIV/AIDS

Thanks for the link Orangetree. Very revealing. Overall I think its time to move on from SBRY.Next time it gets to 280 !!!

Possible danger to SP on the immediate horizon is Gilead's Bictegravir. To date this has proved only non inferior to GSK's best dselling HIV drug. Lets hope more detailed studies to be announced next week by Gilead does not impact negatively here.

of exceptional trading figures and an increase in profitability, I am reluctantly coming to the conclusion after 7 years holding SBRY that I should now consider selling. Does not seem to be able to get back to 300P despite many attempts and the relentless attention of the shorters.

the latest trading figures can now project the sp higher, notwithstanding the dreaded shorters.

still active.Look forward to the time they loose out. Some good trading figures will bring the SP up to 3 quid.

drop way overdone.Look for a bounce in coming days!!

downgrade seems to have hit the SP hard. Besides food inflation any other news here?

Kirit Anymore details on short positi or a reference to look up. Thanks

was more of the same. No real improvement seems to be in sight however the SP rebounding today is a good omen!!!

small signs from SBRY that one hopes can be sustained.

You should have observed by now that there are quite a few people that post regularly on these BBs that have convinced themselves that they actually are the beneficial holders of shares let alone GSK.

Tempted to wait for the outcome of the internal review but valuation looks more than realistic at the moment so I have sold. Great run since Dec16.

Still the 3rd most shorted stock in the FTSE100. One of these hedge funds in particular is betting on SBRY being forced into a rights issue. I hope they are proved to be wrong and pay the appropriate price. Its time SBRY started to show some improved figures that will reduce the shorters' activities and see a sustained increase in the SP. Maybe this can begin to happen in the next 6 months as everyone including me has a limit on their patience.

I have absolutely no doubt that the valuation will be re-rated upwards especially if SBRY's recent acquisition is seeing to be making progress and the sated savings are realized. More patience required!!

Shorters have been very active here for some years now. The market is also extremely sceptical about the Argos acquisition. The SP will move over £3 if and when the acquisition proves to have been a smart decision. The jury is out!!!

comments concerning pace of progress whilst truthful and factual are clearly negative on the SP. Lots of patience required here.

after 3 years holding this share . Always jam tomorrow!!!!! Good luck to all holders.

Results 20/06/2016.